Article Details
Retrieved on: 2024-04-06 17:57:25
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses the financial performance and stock activity of Organigram Holdings Inc., a medical cannabis producer, highlighting adjusted EPS estimates and interest from hedge funds and investment firms like Goldman Sachs in the context of financial markets and equity securities.
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here